EPIQ Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.55M Hold
4,227
– – 0.67% 36
2026
Q2
$1.76M Hold
4,227
– – 0.75% 34
2026
Q1
$1.14M Hold
4,227
– – 0.53% 44
2025
Q4
$1.4M Buy
4,227
+2
+0% +$678 0.65% 40
2025
Q3
$1.46M Buy
4,225
+675
+19% +$204K 0.69% 37
2025
Q2
$1.11M Buy
3,550
+1,550
+78% +$592K 0.56% 41
2025
Q1
$1.05M Hold
2,000
– – 0.55% 43
2024
Q4
$1.01M Hold
2,000
– – 0.55% 41
2024
Q3
$1.17M Hold
2,000
– – 0.65% 37
2024
Q2
$1.02M Hold
2,000
– – 0.69% 36
2024
Q1
$989K Hold
2,000
– – 0.66% 38
2023
Q4
$1.05M Sell
2,000
-178
-8% -$94.9K 0.76% 36
2023
Q3
$1.1M Hold
2,178
– – 0.83% 33
2023
Q2
$1.05M Hold
2,178
– – 0.71% 37
2023
Q1
$1.03M Hold
2,178
– – 0.71% 40
2022
Q4
$1.15M Buy
2,178
+30
+1% +$15.9K 0.77% 40
2022
Q3
$1.08M Hold
2,148
– – 0.67% 43
2022
Q2
$1.1M Buy
2,148
+26
+1% +$13.1K 0.68% 46
2022
Q1
$1.08M Buy
2,122
+122
+6% +$58.8K 0.58% 51
2021
Q4
$1M Hold
2,000
– – 0.54% 51
2021
Q3
$781K Buy
+2,000
New +$828K 0.36% 55

Other funds holding UNH

EPIQ Partners's UNH Position: Q3 2026 in Review

EPIQ Partners held its UnitedHealth (UNH) position steady in Q3 2026 at 4,227 shares worth $1.55M. The position accounts for 0.67% of the portfolio, ranked #36.

EPIQ Partners first reported a position in UNH in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.76M in Q2 2026. 1,147 funds tracked by Wall St. Rank hold UNH as of Q3 2026.

  • EPIQ Partners held 4,227 shares of UnitedHealth worth $1.55M as of Q3 2026.
  • EPIQ Partners left its UnitedHealth share count unchanged in Q3 2026.
  • UnitedHealth made up 0.67% of EPIQ Partners's portfolio in Q3 2026, its #36 holding.
  • EPIQ Partners first reported a position in UnitedHealth in Q3 2021 and has held it in 21 quarters since.
  • EPIQ Partners's UnitedHealth position peaked at $1.76M in Q2 2026.
  • 1,147 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2026.

Based on EPIQ Partners's 13F filing for Q3 2026, filed 7 Oct 2026.